What Aspergillosis Patients Need to Know**
Part of the Aspergillosis Immune System Knowledge Hub
Eosinophils are a type of white blood cell central to allergy, asthma, and ABPA. They play a major role in symptoms, flare-ups, mucus plugging, and treatment responses.
This article explains eosinophils in simple terms.
🧬 1. What Are Eosinophils?
Eosinophils are immune cells filled with granules containing powerful enzymes.
They normally help:
-
fight parasites
-
regulate allergic inflammation
-
repair tissues
-
produce important immune signals
But in excess, they can cause damage — especially in the lungs.
🔥 2. Eosinophils in the Lungs
Activated eosinophils release their granules into airway tissues, causing:
-
swelling
-
increased mucus
-
airway narrowing
-
cough sensitivity
-
wheezing
-
breathlessness
This makes them key players in allergic and fungal-related lung disease.
🌟 3. Eosinophils in ABPA
Eosinophils are highly active in ABPA.
ABPA involves a strong “type-2” allergic response to Aspergillus, including:
-
high IgE
-
mast cell activation
-
large numbers of eosinophils
-
thick, sticky mucus
-
airway obstruction
-
repeated flare-ups
Eosinophils contribute significantly to long-term lung damage if not controlled.
🌬 4. Eosinophils in Severe Asthma and SAFS
In severe or allergic asthma:
-
eosinophils can be persistently high
-
they drive airway swelling
-
they increase sensitivity to triggers
-
they worsen recovery after infection
In SAFS, eosinophils may be moderately raised but symptoms can still be severe.
🦠 5. Eosinophils in CPA
In CPA, eosinophils are not usually the dominant cell, but they still matter when patients also have:
-
asthma
-
ABPA overlap
-
fungal allergy
-
airway hypersensitivity
-
steroid withdrawal flare-ups
🔗 6. How Eosinophils Link to Other Immune Cells
They interact with:
-
IgE → recruits eosinophils
-
T-helper cells (Th2) → tell bone marrow to make more
-
Mast cells → release histamine that pulls eosinophils into tissues
-
Airway lining cells → release distress signals
This is why severe allergic pathways often involve all three:
IgE → mast cells → eosinophils
💊 7. Treatments That Target Eosinophils
✔ Steroids (oral or inhaled)
Suppress eosinophil activity.
✔ Biologics
Directly reduce eosinophils:
-
Mepolizumab (anti-IL-5)
-
Benralizumab (anti-IL-5 receptor)
-
Reslizumab (anti-IL-5 infusion)
Reduce eosinophil recruitment:
-
Dupilumab (anti-IL-4/IL-13)
-
Tezepelumab (broad upstream suppression)
These can transform life for patients with severe asthma or ABPA.
🧠 8. Summary
Eosinophils are key drivers of:
-
flare-ups
-
mucus plugging
-
wheeze
-
breathlessness
-
airway damage
Understanding them helps patients:
-
interpret blood tests
-
understand biologic treatments
-
recognise flare-up patterns
-
manage ABPA and asthma more confidently
Next articles:
Share this post
Latest News posts
Recent Aspergillosis Research – January 2026 (week 2)
January 16, 2026
Sinusitis in Patients with ABPA
January 16, 2026
Hydrocortisone dosing in adrenal insufficiency
January 5, 2026
Season’s Greeting
December 24, 2025
News archive
- ABPA
- Air Quality
- Airway Clearance, Diagnosis & Physiotherapy
- Antifungals
- Aspergilloma
- Aspergillus Bronchitis
- Biologics
- CPA
- Carers & Family
- Communities
- Complementary & Supplements
- Complications
- Conditions
- Diagnostics
- Environment
- Events & Recordings
- GP Guidance
- General interest
- Housing & Damp
- Imaging
- Immune System
- Lifestyle & Coping
- Living with Aspergillosis
- Mental Health
- Monitoring
- Monitoring & Safety
- NAC & Guidance
- NAC Announcements
- Professional Guidance
- Recordings
- Research
- Research Summaries
- SAFS / Severe Asthma
- Side Effects
- Steroids
- Symptoms
- Travel and Insurance
- Treatment
- Vaccines
- Weekly Updates
